PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery

By In The News
May 21, 2019 in The Headlines

Recommended Posts

In The News

Posted May 21, 2019

- Share

Posted May 21, 2019

PETAH TIKVA, Israel, May 21, 2019 PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies, announced today that the United States Food and Drug Administration (FDA) has granted a second Qualified Infectious...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220071
2. Jaydee
  16871
3. Kip Powick
  12238
4. deicer
  12238
5. dagger
  9596
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.4k
- Total Posts
  
  559.2k

Sign In

PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support